Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555561 | 12555556 | 1 | I | 20160704 | 20160714 | 20160714 | EXP | FR-ROCHE-1789089 | ROCHE | FECHTENBAUM M, LASSELIN-BOYARD P, SALOMON S, JELIN G, MILLOT F, GRADOS F, FARDELLONE P AND GOEB V. DECREASE OF TOCILIZUMAB DOSE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PILOT STUDY. PHARMACOLOGY 2016 JUN 01;98 (1-2):73-78. | 0.00 | Y | 0.00000 | 20160714 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555561 | 12555556 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 8 | MG/KG | SOLUTION FOR INFUSION | |||||||
| 125555561 | 12555556 | 2 | SS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 4 | MG/KG | ||||||||
| 125555561 | 12555556 | 3 | SS | Rituximab | RITUXIMAB | 1 | Unknown | 103705 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125555561 | 12555556 | 1 | Rheumatoid arthritis |
| 125555561 | 12555556 | 3 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125555561 | 12555556 | HO |
| 125555561 | 12555556 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125555561 | 12555556 | Bronchitis | |
| 125555561 | 12555556 | Colon cancer | |
| 125555561 | 12555556 | Dysentery | |
| 125555561 | 12555556 | Ear infection | |
| 125555561 | 12555556 | Gastroenteritis | |
| 125555561 | 12555556 | Gastrointestinal infection | |
| 125555561 | 12555556 | Hepatocellular injury | |
| 125555561 | 12555556 | Hypersensitivity | |
| 125555561 | 12555556 | Infection | |
| 125555561 | 12555556 | Laryngitis | |
| 125555561 | 12555556 | Neutropenia | |
| 125555561 | 12555556 | Pancreatitis | |
| 125555561 | 12555556 | Pharyngitis | |
| 125555561 | 12555556 | Pneumonia | |
| 125555561 | 12555556 | Sinusitis | |
| 125555561 | 12555556 | Skin cancer | |
| 125555561 | 12555556 | Skin infection | |
| 125555561 | 12555556 | Thrombocytopenia | |
| 125555561 | 12555556 | Treatment failure | |
| 125555561 | 12555556 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |